Review




Structured Review

Transmet Corporation randomised clinical trial
Randomised Clinical Trial, supplied by Transmet Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomised clinical trial/product/Transmet Corporation
Average 90 stars, based on 1 article reviews
randomised clinical trial - by Bioz Stars, 2026-04
90/100 stars

Images



Similar Products

90
Transmet Corporation randomised clinical trial
Randomised Clinical Trial, supplied by Transmet Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomised clinical trial/product/Transmet Corporation
Average 90 stars, based on 1 article reviews
randomised clinical trial - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Wolters Kluwer Health randomised and nonrandomised clinical trials
Randomised And Nonrandomised Clinical Trials, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomised and nonrandomised clinical trials/product/Wolters Kluwer Health
Average 90 stars, based on 1 article reviews
randomised and nonrandomised clinical trials - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Tayside Pharmaceuticals randomised clinical trial
Characteristics of the studied cohorts.
Randomised Clinical Trial, supplied by Tayside Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomised clinical trial/product/Tayside Pharmaceuticals
Average 90 stars, based on 1 article reviews
randomised clinical trial - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Cardiolink Corporation empa-heart cardiolink-6 randomised clinical trial
Characteristics of the studied cohorts.
Empa Heart Cardiolink 6 Randomised Clinical Trial, supplied by Cardiolink Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/empa-heart cardiolink-6 randomised clinical trial/product/Cardiolink Corporation
Average 90 stars, based on 1 article reviews
empa-heart cardiolink-6 randomised clinical trial - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

99
Gilead Sciences randomised phase 3 clinical trial
Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.
Randomised Phase 3 Clinical Trial, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomised phase 3 clinical trial/product/Gilead Sciences
Average 99 stars, based on 1 article reviews
randomised phase 3 clinical trial - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

Image Search Results


Characteristics of the studied cohorts.

Journal: PLoS ONE

Article Title: LTA4H rs2660845 association with montelukast response in early and late-onset asthma

doi: 10.1371/journal.pone.0257396

Figure Lengend Snippet: Characteristics of the studied cohorts.

Article Snippet: In this study, we utilised a very large dataset, consisting of previously described, ethnically diverse case-control studies (GALA II and SAGE), asthma cohorts (BREATHE and PAGES), a randomised clinical trial (RCT) (Tayside RCT) and two large real-life cohorts (the UKBiobank and GoSHARE), to explore the association of rs2660845 with lack of montelukast treatment response.

Techniques: Variant Assay

Association of exacerbation under montelukast treatment with rs2660845 genotype.

Journal: PLoS ONE

Article Title: LTA4H rs2660845 association with montelukast response in early and late-onset asthma

doi: 10.1371/journal.pone.0257396

Figure Lengend Snippet: Association of exacerbation under montelukast treatment with rs2660845 genotype.

Article Snippet: In this study, we utilised a very large dataset, consisting of previously described, ethnically diverse case-control studies (GALA II and SAGE), asthma cohorts (BREATHE and PAGES), a randomised clinical trial (RCT) (Tayside RCT) and two large real-life cohorts (the UKBiobank and GoSHARE), to explore the association of rs2660845 with lack of montelukast treatment response.

Techniques:

Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

Journal: Biomolecules

Article Title: Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

doi: 10.3390/biom11010091

Figure Lengend Snippet: Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

Article Snippet: Infliximab is currently tested in a randomised phase 3 clinical trial among other immune-modulating candidates for treating COVID-19 as an add-on therapy to the already approved remdesivir (Gilead Sciences, Inc., Foster City, CA, USA) (NCT04593940).

Techniques: Injection, Variant Assay